BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19579169)

  • 21. [Sleep, depression, and antidepressive treatments (1)].
    Arriaga F
    Acta Med Port; 1995 Feb; 8(2):113-7. PubMed ID: 7771204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain, networks, depression, and more.
    Leistedt SJ; Linkowski P
    Eur Neuropsychopharmacol; 2013 Jan; 23(1):55-62. PubMed ID: 23154052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokines, stressors, and clinical depression: augmented adaptation responses underlie depression pathogenesis.
    Simmons DA; Broderick PA
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):793-807. PubMed ID: 15923072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Childhood neglect and abuse as predictors of antidepressant response in adult depression.
    Johnstone JM; Luty SE; Carter JD; Mulder RT; Frampton CM; Joyce PR
    Depress Anxiety; 2009; 26(8):711-7. PubMed ID: 19544315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of neurotransmitters to the symptoms of major depressive disorder.
    Nutt DJ
    J Clin Psychiatry; 2008; 69 Suppl E1():4-7. PubMed ID: 18494537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokines and late-life depression.
    Craddock D; Thomas A
    Essent Psychopharmacol; 2006; 7(1):42-52. PubMed ID: 16989292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Advances in antidepressants and research methods of depression].
    Yang XY; Chen J; Yang XM; Ma SP
    Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):770-4. PubMed ID: 17639970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression.
    Mössner R; Mikova O; Koutsilieri E; Saoud M; Ehlis AC; Müller N; Fallgatter AJ; Riederer P
    World J Biol Psychiatry; 2007; 8(3):141-74. PubMed ID: 17654407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depressive symptomatology is associated with decreased interleukin-1 beta and increased interleukin-1 receptor antagonist levels in males.
    Ovaskainen Y; Koponen H; Jokelainen J; Keinänen-Kiukaanniemi S; Kumpusalo E; Vanhala M
    Psychiatry Res; 2009 May; 167(1-2):73-9. PubMed ID: 19346005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is major depressive disorder a metabolic encephalopathy?
    Harvey BH
    Hum Psychopharmacol; 2008 Jul; 23(5):371-84. PubMed ID: 18435513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [5-HT1A gene polymorphisms contributed to antidepressant response in major depression].
    Kato M; Fukuda T; Wakeno M; Okugawa G; Takekita Y; Serretti A; Azuma J; Kinoshita T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Feb; 29(1):23-31. PubMed ID: 19326813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Editor's Roundtable: major depression in patients with coronary heart disease.
    Friedewald VE; Arnold LW; Carney RM; Jaffe AS; Sheps DS; Roberts WC
    Am J Cardiol; 2007 Feb; 99(4):519-29. PubMed ID: 17293197
    [No Abstract]   [Full Text] [Related]  

  • 33. Identifying difficult-to-treat depression: differential diagnosis, subtypes, and comorbidities.
    Gaynes BN
    J Clin Psychiatry; 2009; 70 Suppl 6():10-5. PubMed ID: 19922739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [What clinicians expect from animal models of depression].
    Nomura S; Shigemura J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):37-9. PubMed ID: 19562939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphodiesterase genes and antidepressant treatment response: a review.
    Esposito K; Reierson GW; Luo HR; Wu GS; Licinio J; Wong ML
    Ann Med; 2009; 41(3):177-85. PubMed ID: 18932104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication.
    Parikh SV; Segal ZV; Grigoriadis S; Ravindran AV; Kennedy SH; Lam RW; Patten SB;
    J Affect Disord; 2009 Oct; 117 Suppl 1():S15-25. PubMed ID: 19682749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.
    Köhler CA; Freitas TH; Stubbs B; Maes M; Solmi M; Veronese N; de Andrade NQ; Morris G; Fernandes BS; Brunoni AR; Herrmann N; Raison CL; Miller BJ; Lanctôt KL; Carvalho AF
    Mol Neurobiol; 2018 May; 55(5):4195-4206. PubMed ID: 28612257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
    Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
    Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.
    Ghaemi SN
    Bipolar Disord; 2008 Dec; 10(8):957-68. PubMed ID: 19594510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokines and their role in depression.
    Wilson DR; Warise L
    Perspect Psychiatr Care; 2008 Oct; 44(4):285-9. PubMed ID: 18826467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.